Organigram Holdings Inc. (TSE:OGI – Get Free Report) insider Megan Mccrae sold 4,163 shares of the company’s stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of C$2.49, for a total transaction of C$10,365.87. Following the completion of the sale, the insider directly owned 25,309 shares in the company, valued at C$63,019.41. This represents a 14.13% decrease in their ownership of the stock.
Megan Mccrae also recently made the following trade(s):
- On Thursday, October 30th, Megan Mccrae sold 2,985 shares of Organigram stock. The stock was sold at an average price of C$2.25, for a total transaction of C$6,716.25.
Organigram Stock Down 2.3%
Shares of Organigram stock traded down C$0.05 during trading on Friday, reaching C$2.11. The company had a trading volume of 117,363 shares, compared to its average volume of 176,953. The company has a debt-to-equity ratio of 3.07, a quick ratio of 2.62 and a current ratio of 3.36. Organigram Holdings Inc. has a fifty-two week low of C$1.22 and a fifty-two week high of C$2.89. The firm’s fifty day moving average is C$2.43 and its 200-day moving average is C$2.11. The company has a market cap of C$282.50 million, a price-to-earnings ratio of 175.83, a price-to-earnings-growth ratio of 0.42 and a beta of 2.16.
About Organigram
Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.
Featured Stories
- Five stocks we like better than Organigram
- How to Invest in Blue Chip Stocks
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- Best Energy Stocks – Energy Stocks to Buy Now
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
- 3 Monster Growth Stocks to Buy Now
- MarketBeat Week in Review – 11/10 – 11/14
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.
